These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early lens changes in Macaca fascicularis monkeys under topical treatment with echothiophate or carbachol studied by slit-image photography. Albrecht M; Bárány E Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):179-87. PubMed ID: 104934 [TBL] [Abstract][Full Text] [Related]
5. Echothiophate iodide cataracts in monkeys. Occurrence despite loss of accommodation induced by retrodisplacement of ciliary muscle. Kaufman PL; Erickson KA; Neider MW Arch Ophthalmol; 1983 Jan; 101(1):125-8. PubMed ID: 6849646 [TBL] [Abstract][Full Text] [Related]
6. Subsensitivity to pilocarpine in primate ciliary muscle following topical anticholinesterase treatment. Bárány EH Invest Ophthalmol; 1975 Apr; 14(4):302-6. PubMed ID: 1123286 [TBL] [Abstract][Full Text] [Related]
7. Glaucoma, miotic therapy and cataract. I. The frequency of anterior subcapsular vacuoles in glaucoma eyes treated with echothiophate (Phospholine Iodide), pilocarpine or pilocarpine-eserine, and in nonglaucomatous untreated eyes with common senile cataract. Axelsson U Acta Ophthalmol (Copenh); 1968; 46(1):83-98. PubMed ID: 5694669 [No Abstract] [Full Text] [Related]
9. Subsensitivity to pilocarpine of the aqueous outflow system in monkey eyes after topical anticholinesterase treatment. Kaufman PL; Bárány EH Am J Ophthalmol; 1976 Dec; 82(6):883-91. PubMed ID: 826164 [TBL] [Abstract][Full Text] [Related]
10. Lens opacities in glaucoma patients on phospholine iodide therapy. De Roetth A Trans Ophthalmol Soc U K (1962); 1966; 86():89-100. PubMed ID: 5226620 [No Abstract] [Full Text] [Related]
11. Glaucoma, miotic therapy and cataract. V. Studies on the lens in glaucoma eyes after discontinuance of echothiophate (phospholine iodide) therapy. Axelsson U Acta Ophthalmol (Copenh); 1969; 47(4):1049-56. PubMed ID: 5394838 [No Abstract] [Full Text] [Related]
12. [Phospholine iodide and opacity of the lens]. Dake CL; Kerlen CH Ned Tijdschr Geneeskd; 1968 Oct; 112(42):1898-901. PubMed ID: 5686456 [No Abstract] [Full Text] [Related]
14. Glaucoma, miotic therapy and cataract. 3. Visual loss due to lens changes in glaucoma eyes treated with paraoxon (Mintacol), echothiophate (phospholine iodide) or pilocarpine. Axelsson U Acta Ophthalmol (Copenh); 1968; 46(4):831-45. PubMed ID: 5755701 [No Abstract] [Full Text] [Related]
15. [Absence of cataractogenic effect of 0.03 percent phospholine iodide]. Corbel M; Leser C; Lemaire E Bull Soc Ophtalmol Fr; 1971; 71(9):885-9. PubMed ID: 5151034 [No Abstract] [Full Text] [Related]
16. Effect of echothiophate iodide on the lens. Morton WR; Drance SM; Fairclough M Am J Ophthalmol; 1969 Dec; 68(6):1003-10. PubMed ID: 5362877 [No Abstract] [Full Text] [Related]
17. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs. Holland MG Ann Ophthalmol; 1974 May; 6(5):447-50 passim. PubMed ID: 4208894 [No Abstract] [Full Text] [Related]
18. Anticholinesterase drugs and cataracts. Shaffer RN; Hetherington J Trans Am Ophthalmol Soc; 1966; 64():204-16. PubMed ID: 6007355 [No Abstract] [Full Text] [Related]
19. Incidence of lens changes in patients treated with echothiophate iodide. Thoft RA Arch Ophthalmol; 1968 Sep; 80(3):317-20. PubMed ID: 5670686 [No Abstract] [Full Text] [Related]